Research News for 2012
-
T-DM1 Granted Priority Review by FDA
The U.S. Food and Drug Administration has granted priority review to T-DM1 to treat HER2-positive, metastatic breast cancer.
-
Exercise and Complete Decongestive Therapy Are Best Ways to Self-Manage Lymphedema
A study that reviewed published research on lymphedema suggests that full-body exercise and complete decongestive therapy are the best ways to minimize lymphedema symptoms and maintain good quality of life.
-
Ginger May Help Ease Nausea Immediately After Chemotherapy
A small study suggests that adding ginger to standard anti-nausea medicines can reduce nausea in women diagnosed with advanced-stage breast cancer immediately after chemotherapy more than the anti-nausea medicines alone.
-
Tykerb and Xeloda Seem to Shrink HER2-Positive Breast Cancer That’s Spread to Brain
A very small, very early study suggests the combination of Tykerb and Xeloda shrinks HER2-positive breast cancer lesions in the brain without radiation.
-
Older Women Have More Complications from Brachytherapy Compared to Whole-Breast Radiation
A study suggests that older women who have brachytherapy are more likely to have complications in the year after treatment compared to women who had whole-breast irradiation.
-
Paxil May Ease Hot Flashes
Two studies suggest that a low dose of the antidepressant medicine Paxil can lower the number and severity of hot flashes in some women.
-
Mammostrat Test Helps Estimate Recurrence Risk and Make Treatment Decisions
A study shows that the Mammostrat test can offer more information on the risk of early-stage, hormone-receptor-positive breast cancer coming back in postmenopausal women and help make treatment decisions.
-
Exercise, Counseling Can Help Ease Menopausal Symptoms Caused by Breast Cancer Treatment
A Dutch study has found that exercise and a type of counseling called cognitive behavioral therapy can help ease menopausal symptoms that often come during and after breast cancer treatment.
-
Fareston Is Effective Against Some Advanced-Stage Cancers That Have Stopped Responding to Aromatase Inhibitors
A small study has found that Fareston is a good treatment option for postmenopausal women diagnosed with advanced-stage hormone-receptor-positive breast cancer that grew while being treated with the aromatase inhibitors Arimidex or Femara.
-
Memory Training Program Seems to Help Thinking and Remembering in Women Who’ve Been Treated for Breast Cancer
A small study has found that a computer-based training program improved the memories of women who've been treated for breast cancer, as well as their ability to quickly process information.
